ACCESS DAXXIFY
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Aug 2031: the §8 declaration of use).
Record
- Serial number
- 98256358
- Registration number
- 7883786
- Mark type
- Word mark
- Filed
- 06 Nov 2023
- Published for opposition
- 03 Sept 2024
- Registered
- 05 Aug 2025
- Next maintenance filing
- §8 declaration of use, due by 05 Aug 2031 (grace period to 05 Feb 2032)
- Attorney of record
- Jennifer Waitman
Goods and services
- Class 036 — Insurance and financial services: Financial management of patient reimbursement programs; Financial administration of medication reimbursement programs; Providing patient financial support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance claims processing information in the nature of information about insurance authorization forms and appeals, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims
Owner
- Revance Therapeutics, Inc., Johnson City, TN, US
- Revance Therapeutics, Inc., Johnson City, TN, US
- Revance Therapeutics, Inc., Newark, CA, US
Prior registrations
Prosecution history
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Mar 2025 — USE AMENDMENT FILED
- 12 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Apr 2025 — ASSIGNED TO EXAMINER
- 15 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT